Henrique Luiz Staub
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Henrique Luiz Staub has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Carlos Alberto von Mühlen
Department of Rheumatology, Faculty of Medicine, PUCRS, Porto Alegre, Brazil
7 shared publicationsAline Ranzolin
Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brasil
4 shared publications- Melissa Cláudia Bisi
Rheumatology Department, Universidade Pontifícia Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
4 shared publications Luiz Carlos Bodanese
3 shared publicationsAndrei Lottermann
Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brasil
2 shared publicationsCarina Rossoni
2 shared publications
Latest Publications
- Open Access
- 11 June 2015
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 54 (8) , 1533-1534
Cocaine abuse, retiform purpura and antiphospholipid syndrome
Sir, Addiction to levamisole-adulterated cocaine (LAC) brought about a new syndrome featuring retiform purpura, neutropenia and the presence of perinuclear ANCAs (p-ANCAs) [1]. Of interest, some LAC users with retiform purpura exhibit thrombotic histology and aPL [1], resembling a true APS [2]. We herein report a case of a cocaine addict with these clinical and histological characteristics.
- 11 June 2015
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 54 (8) , 1533-1534
Open AccessCocaine abuse, retiform purpura and antiphospholipid syndrome
Sir, Addiction to levamisole-adulterated cocaine (LAC) brought about a new syndrome featuring retiform purpura, neutropenia and the presence of perinuclear ANCAs (p-ANCAs) [1]. Of interest, some LAC users with retiform purpura exhibit thrombotic histology and aPL [1], resembling a true APS [2]. We herein report a case of a cocaine addict with these clinical and histological characteristics.
- Open Access
- 1 May 2014
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 54 (3) , 250-254
Ultrassonografia articular: confiabilidade interobservadores em artrite reumatoide
- 1 May 2014
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 54 (3) , 250-254
Open AccessUltrassonografia articular: confiabilidade interobservadores em artrite reumatoide
- Open Access
- 1 July 2013
- Published by Elsevier in Revista Brasileira de Reumatologia
- Vol. 53 (4) , 328-334
Psychiatric symptoms in patients with systemic lupus erythematosus: frequency and association with disease activity using the Adult Psychiatric Morbidity Questionnaire
- 1 July 2013
- Published by Elsevier in Revista Brasileira de Reumatologia
- Vol. 53 (4) , 328-334
Open AccessPsychiatric symptoms in patients with systemic lupus erythematosus: frequency and association with disease activity using the Adult Psychiatric Morbidity Questionnaire
- Open Access
- 11 January 2013
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 17 (1) , 116-117
Olecranon bursitis caused by group C streptococcus in a patient with tophaceous gout
- 11 January 2013
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 17 (1) , 116-117
Open AccessOlecranon bursitis caused by group C streptococcus in a patient with tophaceous gout
- 1 October 2012
- Vol. 52 (5) , 804-10
Posterior reversible encephalopathy syndrome (PRES) and systemic lupus erythematosus: report of two cases.
The posterior reversible encephalopathy syndrome (PRES) is a novel entity clinically manifested by headache, changes of sensorium, seizures, and visual loss. PRES pathogenesis has not been fully clarified. The entity can be associated to a variety of clinical conditions, mainly hypertension, renal insufficiency and immunosuppressive therapy. A possible link of autoimmune disorders with PRES has been recently hypothesized. We herein describe two cases of systemic lupus erythematosus whereby PRES was triggered by different factors.
- 1 October 2012
- Vol. 52 (5) , 804-10
Posterior reversible encephalopathy syndrome (PRES) and systemic lupus erythematosus: report of two cases.
The posterior reversible encephalopathy syndrome (PRES) is a novel entity clinically manifested by headache, changes of sensorium, seizures, and visual loss. PRES pathogenesis has not been fully clarified. The entity can be associated to a variety of clinical conditions, mainly hypertension, renal insufficiency and immunosuppressive therapy. A possible link of autoimmune disorders with PRES has been recently hypothesized. We herein describe two cases of systemic lupus erythematosus whereby PRES was triggered by different factors.
- Open Access
- 1 October 2012
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 52 (5) , 807-810
Síndrome da encefalopatia posterior reversível (PRES) e lúpus eritematoso sistêmico: relato de dois casos
- 1 October 2012
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 52 (5) , 807-810
Open AccessSíndrome da encefalopatia posterior reversível (PRES) e lúpus eritematoso sistêmico: relato de dois casos
- 1 August 2011
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 51 (4) , 385-387
Antimaláricos e perfil lipídico em pacientes com lúpus eritematoso sistêmico
- 1 August 2011
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 51 (4) , 385-387
Antimaláricos e perfil lipídico em pacientes com lúpus eritematoso sistêmico
- 23 July 2011
- Vol. 51 (4) , 383-4, 386
Antimalarials and cholesterol profile of patients with systemic lupus erythematosus.
A beneficial influence of antimalarials on lipid profile of systemic lupus erythematosus (SLE) patients has been recently claimed. In this cross-sectional study, we evaluated the effect of chloroquine on cholesterol levels of a Brazilian population with SLE. Sixty patients were studied, 95% females. Mean age was 48.7 years (SD 13.3 years). Overweight or obesity was documented in 27 cases (45%). Thirty-four patients (56.6%) were using chloroquine in standard dosage, while 33 (55%) were on corticosteroids. Hypercholesterolemia was present in 26 patients (43.3%), while low HDL cholesterol levels were seen in 18 cases (30%). Normal cholesterolemia was documented equally in users and non-users of antimalarials (P > 0.20). After adjustment for statin and corticosteroid intake by multivariate analysis, cholesterol and HDL-cholesterol levels did not significantly differ in users or non-users of chloroquine (P > 0.05). There was no association of chloroquine intake with low body mass index (P = 0.314). Our findings suggest that antimalarial intake by itself does not distinguish cholesterol profiles in SLE patients.
- 23 July 2011
- Vol. 51 (4) , 383-4, 386
Antimalarials and cholesterol profile of patients with systemic lupus erythematosus.
A beneficial influence of antimalarials on lipid profile of systemic lupus erythematosus (SLE) patients has been recently claimed. In this cross-sectional study, we evaluated the effect of chloroquine on cholesterol levels of a Brazilian population with SLE. Sixty patients were studied, 95% females. Mean age was 48.7 years (SD 13.3 years). Overweight or obesity was documented in 27 cases (45%). Thirty-four patients (56.6%) were using chloroquine in standard dosage, while 33 (55%) were on corticosteroids. Hypercholesterolemia was present in 26 patients (43.3%), while low HDL cholesterol levels were seen in 18 cases (30%). Normal cholesterolemia was documented equally in users and non-users of antimalarials (P > 0.20). After adjustment for statin and corticosteroid intake by multivariate analysis, cholesterol and HDL-cholesterol levels did not significantly differ in users or non-users of chloroquine (P > 0.05). There was no association of chloroquine intake with low body mass index (P = 0.314). Our findings suggest that antimalarial intake by itself does not distinguish cholesterol profiles in SLE patients.
- 7 February 2011
- Vol. 138 (12) , 1562
Neurofibromatosis type I and antiphospholipid syndrome.